Pharmaceutical MDL-2996 Open - Limited • CAN

McKinsey & Company, National Prescription Opiate Consultant Litigation

IN RE: McKinsey & Company, Inc., National Prescription Opiate Consultant Litigation

235
Pending Actions
262
Total Actions Filed
10%
Resolution Rate
Active
Status
Updated 2026-05-01

Overview

The McKinsey & Company, National Prescription Opiate Consultant Litigation is a federal multidistrict litigation consolidated in the CAN before Charles R. Breyer (Sr. District Judge). This MDL involves claims related to pharmaceutical issues.

As of 2026-05-01, there are 235 pending actions out of 262 total actions filed, representing a 10% resolution rate.

Who May Qualify

Eligibility for this MDL typically depends on factors such as:

  • Documented exposure to or use of the product/device in question
  • Medical diagnosis of related injuries or conditions
  • Claim filed within the applicable statute of limitations

Key Information

Assigned Judge

Charles R. Breyer (Sr. District Judge)

District Court

CAN

MDL Number

MDL-2996

Category

Pharmaceutical

Attorney Advertising. The information on this page is for general informational purposes only and does not constitute legal advice. No attorney-client relationship is formed by reading this content. Results in MDL cases vary widely; past results do not guarantee future outcomes. If you believe you have a legal claim, consult a licensed attorney in your jurisdiction.